Position in COGT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$28,800,346
-$25,502,346 QoQ
Shares Held
744,195
-47.3% QoQ
Ownership
0.429%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#51
of 321 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in COGT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names. COGT ranks #24 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
4,473,478 | $158,316,386 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,587,712 | $135,257,185 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,525,782 | $113,640,243 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
416,516 | $101,950,621 | |
| 5 | LEGN |
Legend Biotech Corp
|
3,076,124 | $88,838,461 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
137,029 | $73,577,721 | |
| 7 | CELC |
Celcuity Inc.
|
650,916 | $68,098,831 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
2,433,168 | $61,559,150 |
All Filings in COGT
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,800,346 | 744,195 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $54,302,692 | 1,410,826 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $29,393,688 | 827,525 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $17,775,281 | 1,237,833 | Shares | Defined | 2025-11-14 | |
| 2025-09-30 | $82,625,041 | 5,753,833 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $35,267,614 | 4,911,924 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $31,720,314 | 5,295,545 | Shares | Defined | 2025-07-21 | |
| 2024-12-31 | $41,708,955 | 5,347,302 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $113,080,298 | 10,470,398 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $88,265,455 | 10,470,398 | Shares | Defined | 2024-09-16 | |
| 2024-03-31 | $44,864,386 | 6,676,248 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $30,525,714 | 5,191,448 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $36,725,861 | 3,766,755 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $55,471,039 | 4,685,054 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $24,133,993 | 2,236,700 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $5,329,424 | 357,200 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $6,392,347 | 853,451 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,438,002 | 866,900 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $8,454,598 | 1,005,303 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $12,027,900 | 1,483,095 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $5,368,970 | 611,500 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $4,548,150 | 405,000 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||